{
     "PMID": "24719677",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20141124",
     "LR": "20160324",
     "IS": "1942-0994 (Electronic) 1942-0994 (Linking)",
     "VI": "2014",
     "DP": "2014",
     "TI": "Metallothionein-II inhibits lipid peroxidation and improves functional recovery after transient brain ischemia and reperfusion in rats.",
     "PG": "436429",
     "LID": "10.1155/2014/436429 [doi]",
     "AB": "After transient cerebral ischemia and reperfusion (I/R), damaging mechanisms, such as excitotoxicity and oxidative stress, lead to irreversible neurological deficits. The induction of metallothionein-II (MT-II) protein is an endogenous mechanism after I/R. Our aim was to evaluate the neuroprotective effect of MT-II after I/R in rats. Male Wistar rats were transiently occluded at the middle cerebral artery for 2 h, followed by reperfusion. Rats received either MT (10 mug per rat i.p.) or vehicle after ischemia. Lipid peroxidation (LP) was measured 22 h after reperfusion in frontal cortex and hippocampus; also, neurological deficit was evaluated after ischemia, using the Longa scoring scale. Infarction area was analyzed 72 hours after ischemia. Results showed increased LP in frontal cortex (30.7%) and hippocampus (26.4%), as compared to control group; this effect was fully reversed by MT treatment. Likewise, we also observed a diminished neurological deficit assessed by the Longa scale in those animals treated with MT compared to control group values. The MT-treated group showed a significant (P < 0.05) reduction of 39.9% in the infarction area, only at the level of hippocampus, as compared to control group. Results suggest that MT-II may be a novel neuroprotective treatment to prevent ischemia injury.",
     "FAU": [
          "Diaz-Ruiz, Araceli",
          "Vacio-Adame, Patricia",
          "Monroy-Noyola, Antonio",
          "Mendez-Armenta, Marisela",
          "Ortiz-Plata, Alma",
          "Montes, Sergio",
          "Rios, Camilo"
     ],
     "AU": [
          "Diaz-Ruiz A",
          "Vacio-Adame P",
          "Monroy-Noyola A",
          "Mendez-Armenta M",
          "Ortiz-Plata A",
          "Montes S",
          "Rios C"
     ],
     "AD": "Departamento de Neuroquimica, Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Avenida Insurgentes Sur No. 3877, 14269 Mexico City, DF, Mexico. Laboratorio de Neuroproteccion, Facultad de Farmacia, Universidad Autonoma del Estado de Morelos, Mexico. Laboratorio de Neuroproteccion, Facultad de Farmacia, Universidad Autonoma del Estado de Morelos, Mexico. Laboratorio de Neuropatologia, Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Mexico. Laboratorio de Neuropatologia, Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Mexico. Departamento de Neuroquimica, Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Avenida Insurgentes Sur No. 3877, 14269 Mexico City, DF, Mexico. Departamento de Neuroquimica, Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Avenida Insurgentes Sur No. 3877, 14269 Mexico City, DF, Mexico ; Departamento de Sistemas Biologicos de la Universidad Autonoma Metropolitana, Unidad Xochimilco Mexico, Mexico.",
     "AUID": [
          "ORCID: 0000-0002-0138-0784"
     ],
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20140225",
     "PL": "United States",
     "TA": "Oxid Med Cell Longev",
     "JT": "Oxidative medicine and cellular longevity",
     "JID": "101479826",
     "RN": [
          "9038-94-2 (Metallothionein)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Frontal Lobe/drug effects/pathology/physiopathology",
          "Hippocampus/drug effects/pathology/physiopathology",
          "Ischemic Attack, Transient/complications/*drug therapy/pathology/*physiopathology",
          "Lipid Peroxidation/*drug effects",
          "Male",
          "Metallothionein/administration & dosage/pharmacology/*therapeutic use",
          "Rabbits",
          "Rats",
          "Rats, Wistar",
          "Recovery of Function/*drug effects",
          "Reperfusion Injury/complications/*drug therapy/pathology/*physiopathology"
     ],
     "PMC": "PMC3956286",
     "EDAT": "2014/04/11 06:00",
     "MHDA": "2014/12/15 06:00",
     "CRDT": [
          "2014/04/11 06:00"
     ],
     "PHST": [
          "2013/11/14 00:00 [received]",
          "2014/01/04 00:00 [revised]",
          "2014/01/17 00:00 [accepted]",
          "2014/04/11 06:00 [entrez]",
          "2014/04/11 06:00 [pubmed]",
          "2014/12/15 06:00 [medline]"
     ],
     "AID": [
          "10.1155/2014/436429 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Oxid Med Cell Longev. 2014;2014:436429. doi: 10.1155/2014/436429. Epub 2014 Feb 25.",
     "term": "hippocampus"
}